Research use only. Not for human consumption. 18+ only.

Cognitive Enhancement / Intravenous / Intramuscular

Cerebrolysin

Also known as FPF-1070, Brain-derived peptides

Cerebrolysin is a mixture of neurotrophic peptides derived from pig brain. It mimics the effects of neurotrophic factors and shows promise for neurodegenerative diseases and traumatic brain injury.

What is Cerebrolysin used for? Research has focused on neuroprotective and neurotrophic effects; may improve cognitive function; supports stroke recovery.

Compare with other peptides studied forcognitive performance,recovery and healing

Evidence grade BCompoundable

Cerebrolysin injection at a glance

Figures from the published research literature. Research use only.

Dose range
5-30 mL
Route
Intravenous, Intramuscular

How often, when, and the dosing notes are in the dosing reference further down.

Beginner basics

Plain-English guide to Cerebrolysin

What it does
Cerebrolysin is a brain-derived mixture that researchers use to protect brain cells and support brain health. It's commonly studied for helping with memory, thinking clarity, and recovery from brain injuries or cognitive decline.
Typical dose
Researchers typically use 5-30 mL injected either into a vein (IV) or muscle (IM), usually once daily for 10-30 days, followed by a break before repeating.
When to inject
Morning injections are most common. Researchers typically run cycles of treatment for 10-30 days, then take a break before starting another cycle.
Storage
Keep the sealed vial at room temperature before opening. Once mixed with liquid, store it in the refrigerator and use within a few days.
Beginner tip
Start with the lowest dose in the range (around 5 mL) to see how your body responds, and always follow a cycle pattern with breaks to avoid your body becoming less responsive.

Research status

Evidence grade B
Smaller human trials, observational studies, or approved in 30 or more countries.
Compoundable
Legal to compound in the US, and approved in other jurisdictions or with a history of approval.

Approved in some countries, research compound in others

For research purposes only. Not approved for human use. Not medical advice.

Research areas

  • Neuroprotective and neurotrophic effects
  • May improve cognitive function
  • Supports stroke recovery
  • Potential for Alzheimer's and dementia
  • Enhances neuroplasticity
  • Improves TBI recovery

Side effects

EffectHow oftenSeverity
Injection site pain or discomfortOccurs at IM or IV injection sites. Typically resolves within 24 hours. Reduce by allowing solution to warm to room temperature before injection and rotating injection sites. Apply ice if needed.CommonMild
Mild headacheMay occur during the first few days of treatment. Usually self-resolving. Ensure adequate hydration and rest.UncommonMild
Dizziness or lightheadednessMore common with IV administration. Sit or lie down if symptoms occur. Typically resolves within minutes to hours.UncommonMild
NauseaMay occur, especially with IV administration. Take with food if tolerated. Symptoms usually resolve within 24 hours.UncommonMild
Fever or chillsRare; may indicate a reaction to the porcine-derived material. Monitor temperature. If fever persists beyond 24 hours, seek medical evaluation.RareMild
Allergic reaction (rash, urticaria, angioedema)Cerebrolysin is derived from porcine brain tissue; individuals with porcine protein allergies are at higher risk. Symptoms may include itching, hives, facial swelling, or difficulty breathing. Seek immediate medical attention if any signs of anaphylaxis occur. Have antihistamines and epinephrine available.RareSerious
Phlebitis or thrombophlebitis (IV administration)Inflammation of the vein at the IV site. Risk increases with prolonged IV infusions or repeated use of the same vein. Rotate IV sites and use proper aseptic technique. Symptoms include redness, warmth, swelling, or pain along the vein. Seek medical evaluation if symptoms develop.UncommonModerate
Muscle pain or myalgiaMay occur at or near IM injection sites. Usually resolves within 48 hours. Apply heat or take over-the-counter analgesics if needed.UncommonMild
Insomnia or sleep disturbanceCerebrolysin may have mild stimulant-like effects on the central nervous system. Avoid injections late in the day. Symptoms typically resolve after treatment discontinuation.UncommonMild
Agitation or anxietyRare; may occur in sensitive individuals. Usually mild and self-resolving. Discontinue if symptoms are bothersome and consult a healthcare provider.RareMild
SeizuresVery rare; reported in isolated cases, particularly in individuals with a history of seizure disorders. Cerebrolysin should be used with caution in patients with epilepsy. Seek immediate medical attention if seizure activity occurs.RareSerious

Dosing reference

Dose scale from the research

Starting
5 mL
Typical
10 mL
Upper end
20 mL
Cerebrolysin dosing reference
ParameterValue
Dose range5-30 mL
Frequency, timing and route are for members

Checked October 2026

Research disclaimer. Figures are drawn from published research literature and community logs. They are not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution guide

  • Do not use saline or bacteriostatic saline, use only bacteriostatic water for reconstitution
  • Do not shake the vial vigorously; gentle swirling prevents peptide degradation
  • Discard immediately if the solution appears cloudy, discolored, or contains visible particles
  • Use within 30 days of reconstitution when stored at 2-8°C
  • Do not freeze the reconstituted solution; freezing may denature the peptide
  • Use the PeptideVolt reconstitution calculator for your exact concentration
Work out your exact dose in the free peptide calculator

Storage and stability

Room temperature before opening, refrigerate after

Molecular and pharmacological data

Half-lifeApproximately 6-8 hours (estimated from clinical pharmacokinetics; exact half-life varies by individual peptide components)

Cerebrolysin is a standardised mixture of neuropeptides and amino acids derived from porcine brain tissue that mimics the effects of endogenous neurotrophic factors, particularly nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). It crosses the blood-brain barrier and promotes neuronal survival, differentiation, and synaptic plasticity through activation of neurotrophic signalling pathways. The peptide mixture enhances cellular energy metabolism and reduces neuroinflammation, making it a candidate for treating neurodegenerative conditions and traumatic brain injury.

Pathways and mechanism detail are for members

Keep a log of your Cerebrolysin research

Free account. No credit card required.

Recent research

All results on PubMed

Source: PubMed / NCBI. Updated daily. Articles are listed for research reference only.

Research citations

2 sources
  • Cerebrolysin neurotrophic effects

  • Peptide mixture cognitive enhancement

All Cognitive Enhancement peptides

Cerebrolysin in blends

Browse the research library

147 peptide profiles and 59 blend profiles with mechanism summaries, dosing data and reconstitution guides.

View all peptides

Stay updated on Cerebrolysin research

A weekly digest of new peptide research, stack guides and site updates.

Research use only. All content on this page is provided for informational and educational purposes related to scientific research. Cerebrolysin is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.